Replies to post #20439 on Relief Therapeutics Holding AG (RLFTF)

[aGuyUS]

I'd speculate 100% or Very Very close you could even state 105% because

If the data in the CRUZ study is any indication it would be 100% as a NAsal treatment. Even the clinical trial for the moderately ill is stating or has been stated somewhere the Inhaler participants can be non hospitalized and stay at home. So they are trying to see if this is effective early treatment, which means

Medical Doctors wil Script this drug as a JUST in CASE you think you were exposed treatment to people once it has enough manufacturing capacity and is widely available


I am more concerned with the Manufacturing capability